Influenza, Human

• 

  Subject Areas on Research

  • 1918 Influenza Pandemic: In Utero Exposure in the United States and Long-Term Impact on Hospitalizations. 
  • 2009 H1N1 and seasonal influenza immunization among pregnant women: a comparison of different sources of immunization information. 
  • A Distinct Function of Regulatory T Cells in Tissue Protection. 
  • A Prevalent Focused Human Antibody Response to the Influenza Virus Hemagglutinin Head Interface. 
  • A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice. 
  • A central role for palliative care in an influenza pandemic. 
  • A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. 
  • A host-based RT-PCR gene expression signature to identify acute respiratory viral infection. 
  • A seroepidemiological study of pandemic A/H1N1(2009) influenza in a rural population of Mali. 
  • A shortened interval between vaccinations with the trivalent inactivated influenza vaccine increases responsiveness in the aged. 
  • A spatio-temporal absorbing state model for disease and syndromic surveillance. 
  • Acute infectious morbidity in multiple gestation. 
  • Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia. 
  • Alteration in regulation of inflammatory response to influenza a virus and endotoxin in suckling rat pups: a potential relationship to sudden infant death syndrome. 
  • An Infection Control Program for a 2009 influenza A H1N1 outbreak in a university-based summer camp. 
  • An international perspective on hospitalized patients with viral community-acquired pneumonia. 
  • An under-recognized influenza epidemic identified by rapid influenza testing, southern Sri Lanka, 2013. 
  • Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial. 
  • Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial. 
  • Are People Living Near Modern Swine Production Facilities at Increased Risk of Influenza Virus Infection? 
  • Assessment of the Feasibility of Using Noninvasive Wearable Biometric Monitoring Sensors to Detect Influenza and the Common Cold Before Symptom Onset. 
  • Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial. 
  • Attitude, intention, and barriers toward influenza vaccination among pregnant women in South Korea 
  • Attitudes and Beliefs of Patients With Left-Ventricular Assist Devices Toward COVID-19 Vaccination and Willingness to Seek Care During the Pandemic. 
  • B cell responses to the 2011/12-influenza vaccine in the aged. 
  • Barriers to influenza immunization in a low-income urban population. 
  • Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates. 
  • Burden of influenza-related hospitalizations among children with sickle cell disease. 
  • C-reactive protein response to influenza vaccination predicts cardiovascular disease risk in the Philippines. 
  • Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions. 
  • Caregiver psychological distress as a barrier to influenza vaccination among community-dwelling elderly with dementia. 
  • Cause specific mortality patterns among the oldest old: multiple cause of death trends 1968 to 1980. 
  • Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine. 
  • Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection. 
  • Cigarette smoking and hemagglutination inhibition response to influenza after natural disease and immunization. 
  • Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. 
  • Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children. 
  • Clinical presentation and response to treatment of novel influenza A H1N1 in a university-based summer camp population. 
  • Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity. 
  • Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009. 
  • Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals. 
  • Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States. 
  • Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. 
  • Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department. 
  • DNA mismatch repair is required for the host innate response and controls cellular fate after influenza virus infection. 
  • DNA vaccines. 
  • Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification. 
  • Depressed monocyte chemotaxis during acute influenza infection. 
  • Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG. 
  • Development of a collaborative program to provide extracorporeal membrane oxygenation for adults with refractory hypoxemia within the framework of a pandemic. 
  • Development of an objective gene expression panel as an alternative to self-reported symptom scores in human influenza challenge trials. 
  • Diagnostic accuracy and cost analysis of the Alere™ i Influenza A&B near-patient test using throat swabs. 
  • Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge. 
  • Dobson backed NICE ruling on flu drug. 
  • Does cost savings mean cost effective? 
  • Does exposure to CS gas potentiate the severity of influenza? 
  • Does influenza vaccination or RSV prophylaxis impact resource utilization for children after the diagnosis of airway disorders? 
  • Does this patient have influenza? 
  • Dysregulated transcriptional responses to SARS-CoV-2 in the periphery. 
  • Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. 
  • Educational content and the effectiveness of influenza vaccination reminders. 
  • Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis. 
  • Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial. 
  • Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis. 
  • Effectiveness of a pay-it-forward intervention compared with user-paid vaccination to improve influenza vaccine uptake and community engagement among children and older adults in China: a quasi-experimental pragmatic trial. 
  • Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. 
  • Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study. 
  • Elementary school-located influenza vaccine programs: key stakeholder experiences from initiation to continuation. 
  • Epidemiology and Outcomes of SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome in Children vs Influenza Among Critically Ill Children. 
  • Epitranscriptomic Enhancement of Influenza A Virus Gene Expression and Replication. 
  • Etiology of pediatric fever in western Kenya: a case-control study of falciparum malaria, respiratory viruses, and streptococcal pharyngitis. 
  • Evaluating the role of blood collection centers in public health: a status report. 
  • Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A. 
  • Factors Associated With Parental Acceptance of COVID-19 Vaccination: A Multicenter Pediatric Emergency Department Cross-Sectional Analysis. 
  • From high-throughput to therapeutic: host-directed interventions against influenza viruses. 
  • GPER1 is required to protect fetal health from maternal inflammation. 
  • Gene Expression Profiles Link Respiratory Viral Infection, Platelet Response to Aspirin, and Acute Myocardial Infarction. 
  • Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. 
  • Global infections: recognition, management, and prevention. 
  • Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. 
  • H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trials. 
  • H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. 
  • Heterogeneity of Antiviral Responses in the Upper Respiratory Tract Mediates Differential Non-lytic Clearance of Influenza Viruses. 
  • High Rates of Influenza-Associated Invasive Pulmonary Aspergillosis May Not Be Universal: A Retrospective Cohort Study from Alberta, Canada. 
  • High Risk of Influenza Virus Infection Among Swine Workers: Examining a Dynamic Cohort in China. 
  • High intensive care unit admission rate for 2013-2014 influenza is associated with a low rate of vaccination. 
  • High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial. 
  • Household Transmission of Influenza A Viruses in 2021-2022. 
  • How Influenza Vaccination Rate Variation Could Inform Pandemic-Era Vaccination Efforts. 
  • How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza as an example. 
  • Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. 
  • IL-1 and TNFα Contribute to the Inflammatory Niche to Enhance Alveolar Regeneration. 
  • Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older. 
  • Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. 
  • Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial. 
  • Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial. 
  • Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. 
  • Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination. 
  • Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. 
  • Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort. 
  • Impact of patient education on influenza vaccine uptake among community-dwelling elderly: a randomized controlled trial. 
  • Implementation of a rapid influenza A/B and RSV direct molecular assay improves emergency department oseltamivir use in paediatric patients. 
  • Improving Influenza Prevention: Modest Changes With Large Effects. 
  • In Vivo Profiling of Individual Multiciliated Cells during Acute Influenza A Virus Infection. 
  • Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND). 
  • Increased T-bet is associated with senescence of influenza virus-specific CD8 T cells in aged humans. 
  • Increasing Influenza Immunization Rates Among Retail Employees: An Evidence-Based Approach. 
  • Individual and Joint Effects of Influenza-Like Illness and Vaccinations on Stroke in the Young: A Case-Control Study: Can You Catch a Stroke? 
  • Individual differences in self-regulatory failure and menstrual dysfunction predict upper respiratory infection symptoms and antibody response to flu immunization. 
  • Infant Antibody Repertoires during the First Two Years of Influenza Vaccination. 
  • Inflammation and Metabolism of Influenza-Stimulated Peripheral Blood Mononuclear Cells From Adults With Obesity Following Bariatric Surgery. 
  • Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy. 
  • Influenza Adherence Tool Kit: Implementation and Evaluation Among Allogeneic Hematopoietic Transplantation Recipients
. 
  • Influenza Vaccination in Patients With Heart Failure. 
  • Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study. 
  • Influenza and Antibody-Dependent Cellular Cytotoxicity. 
  • Influenza and tetanus, diphtheria, and acellular pertussis vaccinations during pregnancy. 
  • Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain. 
  • Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. 
  • Influenza research in the Soviet Union--1974. 
  • Influenza vaccination in children with neurologic or neurodevelopmental disorders. 
  • Influenza vaccination of household contacts of newborns: a hospital-based strategy to increase vaccination rates. 
  • Influenza vaccination practices of physicians and caregivers of children with neurologic and neurodevelopmental conditions - United States, 2011-12 influenza season. 
  • Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020. 
  • Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? 
  • Influenza vaccine uptake among children and older adults in China: a secondary analysis of a quasi-experimental study. 
  • Innate-like Gene Expression of Lung-Resident Memory CD8+ T Cells during Experimental Human Influenza: A Clinical Study. 
  • Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59®-adjuvanted pandemic 2009 H1N1 vaccine. 
  • Knowledge, attitudes and practices towards avian influenza among live poultry market workers in Chongqing, China. 
  • Local influenza-like illness surveillance at a university health system during the 2009 H1N1 influenza pandemic. 
  • Long-term surviving influenza infected cells evade CD8+ T cell mediated clearance. 
  • Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections. 
  • Low-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center. 
  • Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review. 
  • Managing SARS. 
  • Maternal exposure to ultrafine particles enhances influenza infection during pregnancy. 
  • Maternal immunization to benefit the mother, fetus, and infant. 
  • Maternal immunization: opportunities for scientific advancement. 
  • Metabolic and functional impairment of CD8+ T cells from the lungs of influenza-infected obese mice. 
  • Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness Estimates. 
  • Modelling the linkage between influenza infection and cardiovascular events via thrombosis. 
  • Morbidity of late-season influenza during pregnancy. 
  • Moving toward prime time: host signatures for diagnosis of respiratory infections. 
  • Multifactorial influences underpinning a decision on COVID-19 vaccination among healthcare workers: a qualitative analysis. 
  • NICE to rule on influenza flu drug zanamivir. 
  • Nasopharyngeal Protein Biomarkers of Acute Respiratory Virus Infection. 
  • Nonrespiratory sites of influenza-associated disease: mechanisms and experimental systems for continued study. 
  • Nosocomial influenza A (H1N1) infection. 
  • Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection. 
  • Obesity Dysregulates the Immune Response to Influenza Infection and Vaccination Through Metabolic and Inflammatory Mechanisms. 
  • Obesity and receipt of clinical preventive services in veterans. 
  • Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial. 
  • Outcomes of Acute Kidney Injury in Patients With Severe ARDS Due to Influenza A(H1N1) pdm09 Virus. 
  • Outcomes of a Negative Rapid Influenza Diagnostic Test in Pregnant Women. 
  • Pandemic (H1N1) 2009 and oseltamivir resistance in hematology/oncology patients. 
  • Pandemic Vaccine Trials in Low- and Middle-Income Countries and Global Health Security. 
  • Perceptions of Glove Use During Vaccination: A Cross-Sectional Study. 
  • Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. 
  • Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009. 
  • Physicians recommend different treatments for patients than they would choose for themselves. 
  • Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. 
  • Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013. 
  • Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. 
  • Preparing for an influenza pandemic: are some people more equal than others? 
  • Prevalence of influenza A virus in live-captured North Atlantic gray seals: a possible wild reservoir. 
  • Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season. 
  • Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season. 
  • Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season. 
  • Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season. 
  • Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase. 
  • Preventive Care Delivery to Young Children With Sickle Cell Disease. 
  • Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood. 
  • Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs. 
  • Reaching children never previously vaccinated for influenza through a school-located vaccination program. 
  • Real-Time Surveillance of Influenza Morbidity: Tracking Intensive Care Unit Resource Utilization. 
  • Reply to Ku et al. 
  • Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1, 2015. 
  • Rescue therapy in adult and pediatric patients with pH1N1 influenza infection: a tertiary center intensive care unit experience from April to October 2009. 
  • Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease. 
  • Respiratory viral infections in lung transplant recipients: radiologic findings with clinical correlation. 
  • Responding to AIDS, tuberculosis, malaria, and emerging infectious diseases in Burma: dilemmas of policy and practice. 
  • Reversible cardiac dysfunction associated with pandemic 2009 influenza A(H1N1). 
  • Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. 
  • SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. 
  • SO2 levels and perturbations in mortality. A study in the New York-New Jersey metropolis. 
  • Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine. 
  • Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women. 
  • Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants. 
  • Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study. 
  • Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents. 
  • Safety of Live Attenuated Influenza Vaccine in Children With Asthma. 
  • Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial. 
  • Seasonal and novel H1N1 influenza vaccination at a children's hospital. 
  • Selective sweeps in SARS-CoV-2 variant competition. 
  • Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease. 
  • Stemming Lung Disease? 
  • Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective. 
  • Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies. 
  • Successful use of extracorporeal membrane oxygenation for pH1N1-induced refractory hypoxemia in a child with hypoplastic left heart syndrome. 
  • Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era. 
  • Systems biology of vaccination for seasonal influenza in humans. 
  • Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection. 
  • Temporal trends in U. S. multiple cause of death mortality data: 1968 to 1977. 
  • The Development and Use of Reporter Influenza B Viruses. 
  • The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. 
  • The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children. 
  • The effect of timing of influenza vaccination and sample collection on antibody titers and responses in the aged. 
  • The effective rate of influenza reassortment is limited during human infection. 
  • The efficacy of influenza vaccination in healthcare workers in a tropical setting: a prospective investigator blinded observational study. 
  • The ethics of care: social workers in an influenza pandemic. 
  • The host response to infection: advancing a novel diagnostic paradigm. 
  • The impact of host immune status on the within-host and population dynamics of antigenic immune escape. 
  • Transmissibility of swine flu at Fort Dix, 1976. 
  • Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study. 
  • Unsupervised Bayesian linear unmixing of gene expression microarrays. 
  • Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018-19 Influenza Season. 
  • Use of Rapid Influenza Testing to Reduce Antibiotic Prescriptions Among Outpatients with Influenza-Like Illness in Southern Sri Lanka. 
  • Use of extracorporeal life support in adults with severe acute respiratory failure. 
  • Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. 
  • Vaccinations for pregnant women. 
  • Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022. 
  • Vaccine immunogenicity in injecting drug users: a systematic review. 
  • Wearable Sensor-Based Detection of Influenza in Presymptomatic and Asymptomatic Individuals. 
  • Women's views about participating in research while pregnant. 
  • β-Cyclodextrin-containing polymer treatment of cutaneous lupus and influenza improves outcomes. 
• 

  Keywords of People

  • Al-Hegelan, Mashael, Associate Professor of Medicine, Medicine, Pulmonary, Allergy, and Critical Care Medicine
  • Clements III, Dennis Alfred, Professor Emeritus of Pediatrics, Pediatrics, General Pediatrics and Adolescent Health
  • Kelsoe, Garnett H., James B. Duke Distinguished Professor of Immunology, Integrative Immunobiology
  • McClain, Micah Thomas, Associate Professor of Medicine, Medicine, Infectious Diseases
  • Tsalik, Ephraim, Adjunct Associate Professor in the Department of Medicine, Medicine, Infectious Diseases
  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine